Showing results (91-100 of 275) with videos related to
Sort By:
Pageof 28
Microbes and Infection|September 21, 2023
Identification of SARS-CoV-2 m6A modification sites correlate with viral pathogenicityKe Liu, Ying-Zi Zhang, Hui Yin, et al.Journal of Cancer|June 4, 2020
Association of variations in platinum resistance-related genes and prognosis in lung cancer patientsYuan-Kang Zhou, Xiang-Ping Li, Ji-Ye Yin, et al.Optometry and Vision Science : Official Publication of the American Academy of Optometry|November 20, 2015
Identification of MFRP Mutations in Chinese Families with High HyperopiaYan Xu, Liping Guan, Xueshan Xiao, et al.Molecular Therapy. Nucleic Acids|May 4, 2022
Pharmacoepitranscriptomic landscape revealing m6A modification could be a drug-effect biomarker for cancer treatmentKe Liu, Qian-Ying Ouyang, Yan Zhan, et al.Journal of Thoracic Disease|August 3, 2018
Functional miRNA variants affect lung cancer susceptibility and platinum-based chemotherapy responseChao Fang, Xiang-Ping Li, Yi-Xin Chen, et al.Oncology Reports|January 12, 2017
Silencing of Forkhead box D1 inhibits proliferation and migration in glioma cellsYuan-Feng Gao, Tao Zhu, Xiao-Yuan Mao, et al.Biochemical Pharmacology|August 25, 2009
Novel immunomodulatory properties of cirsilineol through selective inhibition of IFN-gamma signaling in a murine model of inflammatory bowel diseaseYang Sun, Xing-Xin Wu, Ye Yin, et al.Acta Pharmacologica Sinica|February 16, 2021
Response prediction biomarkers and drug combinations of PARP inhibitors in prostate cancerYi-Xin Chen, Li-Ming Tan, Jian-Ping Gong, et al.Frontiers in Pharmacology|August 28, 2020
The Association Between Heat-Shock Protein Polymorphisms and Prognosis in Lung Cancer Patients Treated With Platinum-Based ChemotherapyTing Zou, Jun-Yan Liu, Li She, et al.Journal of Cancer|June 18, 2019
The Prospective Value of Dopamine Receptors on Bio-Behavior of TumorXu Wang, Zhi-Bin Wang, Chao Luo, et al.Pageof 28